Blog
RSS FeedPosted by Michael Wonder on 17 Apr 2018
Governments must speed up access to approved cancer drugs
16 April 2018 - Strides in cancer research have increased survival rates and provided a better quality of life for ...
Posted by Michael Wonder on 16 Apr 2018
Private health care in Australia: health policy’s wicked problem
16 April 2018 - The anguish expressed by many of the 1,200 respondents to the Consumers Health Forum’s Out of ...
Posted by Michael Wonder on 16 Apr 2018
CADTH 2018-2021 strategic plan
16 April 2018 - Dr. Brian O’Rourke, CADTH President and CEO, has released the CADTH 2018-2021 Strategic Plan. ...
Posted by Michael Wonder on 16 Apr 2018
WA accuses Canberra of $1 billion health care rip-off
16 April 2018 - West Australians are missing out on $1 billion in federal health funding in a "Canberra rip-off", ...
Posted by Michael Wonder on 16 Apr 2018
Private health insurance analysis shows double-digit rise in some premiums
15 April 2018 - Consumer group Choice says in one case a private provider increased costs by 45%. ...
Posted by Michael Wonder on 15 Apr 2018
Doctors, drug and tech experts converge on Halifax for symposium
13 April 2018 - As a frontline health-care provider and addictions specialist, Dr. David Martell sees the advent of drug ...
Posted by Michael Wonder on 15 Apr 2018
Critical drugs could be rationed following EpiPen shortage
13 April 2018 - Critical medicines could be rationed in Australia in the wake of an EpiPen shortage that left ...
Posted by Michael Wonder on 15 Apr 2018
Hodgkin's patients have Keytruda cost cut
15 April 2018 - Patients with a form of Hodgkin lymphoma will have the cost of a breakthrough drug slashed ...
Posted by Michael Wonder on 13 Apr 2018
Decision components of NICE's technology appraisals assessment framework
10 April 2018 - The UK's NICE is an established health technology assessment agency. de Folter et al. present a ...
Posted by Michael Wonder on 12 Apr 2018
Agenda for April 18 meeting
12 April 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 12 Apr 2018
Chemotherapy compounder ID mandatory within PBS claims
12 April 2018 - The inclusion of the Compounder ID field within a claim for eligible Pharmaceutical Benefits Schedule (PBS) ...
Posted by Michael Wonder on 11 Apr 2018
Use of Merck's Bavencio (avelumab) on NHS supported by NICE
11 April 2018 - Draft final guidance proposes different access streams for first-line and second-line use in patients with Merkel ...
Posted by Michael Wonder on 10 Apr 2018
Wasteful, wrong-headed
10 April 2018 - Universal plan most efficient way to provide quality and effective medicines. ...
Posted by Michael Wonder on 10 Apr 2018
Innovative drugs need a new regulatory approach
10 April 2018 - Innovative drugs help people enjoy longer, healthier, more productive lives. They also allow our health-care systems ...
Posted by Michael Wonder on 09 Apr 2018
Five new medicines accepted by SMC for use by NHSScotland
9 April 2018 - The SMC, has today published advice accepting five new medicines for use by NHSScotland. ...